DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13260
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMahesh, R.-
dc.date.accessioned2023-11-24T09:17:49Z-
dc.date.available2023-11-24T09:17:49Z-
dc.date.issued2011-
dc.identifier.urihttps://pharmacologyonline.silae.it/files/newsletter/2011/vol2/086.bhatt.pdf-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13260-
dc.description.abstractCancer is the leading cause of death worldwide. Over 2 million people in the UK alone are currently living with the consequences of cancer and its treatment and this figure is projected to grow at more than 3% in a year. However, despite major improvements in diagnostic tools, patient management and cytotoxic therapies during the past quarter century, the impact on longterm survival has been modest. As our knowledge of the molecular biology of cancers in general has increased exponentially during the last 2 decades, multiple new targets have been identified and they provide a host of new approaches. This review addressed some of the recent approaches and idea for the treatment of cancer.en_US
dc.language.isoenen_US
dc.publisherPharmacologyonlineen_US
dc.subjectPharmacyen_US
dc.subjectCanceren_US
dc.subjectTumorigenesisen_US
dc.subjectMalignanciesen_US
dc.subjectTherapeutic targetsen_US
dc.titleNewer targets for cancer: a reviewen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.